| Ministry of Health, AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff Setting]. | 癌症
> 癌症：大多数类型 | 监管合作伙伴关系
> 与监管机构合作 | 100,000 | National | Regularly | 114997934765 |
| Collaboration with AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System], RPP [Rzecznik Praw Pacjenta – Patient Rights Ombudsman], and MZ [Ministerstwo Zdrowia – Ministry of Health]. | 风湿性
> 风湿性疾病：大多数类型 | 监管合作伙伴关系
> 与监管机构合作 | Do not know | National | Sometimes | 115034231072 |
| The Ministry of Health, the Parliamentary Bureau for Rare Diseases, and the Agency for Health Technology Assessment [in Poland]. | 神经退行性
> 亨廷顿病 | 监管合作伙伴关系
> 参与卫生技术评估（HTA）和报销审查 | 10,000 | National | Regularly | 114998054778 |
| Patients have one reimbursed therapy; she has therefore participated in AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff Setting] consultations on that single occasion. | 神经系统
> 神经纤维瘤病（NF） | 监管合作伙伴关系
> 参与卫生技术评估（HTA）和报销审查 | 10,000 | National | Rarely | 115001091579 |
| Opinions solicited by AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System]. | 血液
> 血液疾病：大多数类型 | 监管合作伙伴关系
> 参与卫生技术评估（HTA）和报销审查 | 10,000 | National | Sometimes | 115012243141 |
| Participation in subcommittees of the Sejm [lower house of the bicameral parliament of Poland] and at AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff Setting]. | 神经肌肉
> 神经肌肉疾病：大多数类型 | 监管合作伙伴关系
> 参与卫生技术评估（HTA）和报销审查 | 100 | National | Regularly | 115016498985 |
| AOTM [Agencja Oceny Technologii Medycznych – Agency for Health Technology Assessment], MZ [Ministerstwo Zdrowia – Ministry of Health], and NFZ [Narodowy Fundusz Zdrowia – National Health Fund] — meetings. | 神经系统
> 多发性硬化症 | 监管合作伙伴关系
> 参与卫生技术评估（HTA）和报销审查 | 10,000 | National | Regularly | 115020534401 |
| Participation in meetings of the AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System] Transparency Council, as well as meetings at the Ministry of Health, including with the Department of Medicines Policy and Pharmacy. | 慢性
> 自助小组 | 监管合作伙伴关系
> 参与卫生技术评估（HTA）和报销审查 | 5,000 | National | Regularly | 115028436607 |
| AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System]; drug programmes. | 肾脏
> 肾脏疾病 | 监管合作伙伴关系
> 参与卫生技术评估（HTA）和报销审查 | 10,000 | National | Regularly | 115028692487 |
| ... Direct meetings with representatives of the Ministry of Health [in Poland] and NFZ [Narodowy Fundusz Zdrowia – National Health Fund]; participation in conferences and debates involving the MZ [Ministerstwo Zdrowia – Ministry of Health], NFZ, and AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System]. | 总体健康
> 肥胖症 | 监管合作伙伴关系
> 参与卫生技术评估（HTA）和报销审查 | 100,000 | National | Regularly | 115034209832 |
| Collaboration with AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System], RPP [Rzecznik Praw Pacjenta – Patient Rights Ombudsman], and MZ [Ministerstwo Zdrowia – Ministry of Health]. | 风湿性
> 风湿性疾病：大多数类型 | 监管合作伙伴关系
> 参与卫生技术评估（HTA）和报销审查 | Do not know | National | Sometimes | 115034231072 |
| AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff Setting] consultations concerning an innovative therapy for paediatric patients with NF [Neurofibromatosis]. | 神经系统
> 神经纤维瘤病（NF） | 监管合作伙伴关系
> 参与卫生技术评估（HTA）和报销审查 | 1,000 | National | Rarely | 115040684008 |
| Participation in meetings of the Transparency Council of AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System]. | 呼吸系统
> 肺纤维化 | 监管合作伙伴关系
> 参与卫生技术评估（HTA）和报销审查 | 100 | National | Rarely | 115044635845 |
| Meetings at the MZ [Ministerstwo Zdrowia – Ministry of Health]. | 出血
> 出血性疾病：大多数类型 | 监管合作伙伴关系
> 参加/主持与政策制定者/监管机构的会议 | 100 | National | Regularly | 115017164453 |
| AOTM [Agencja Oceny Technologii Medycznych – Agency for Health Technology Assessment], MZ [Ministerstwo Zdrowia – Ministry of Health], and NFZ [Narodowy Fundusz Zdrowia – National Health Fund] — meetings. | 神经系统
> 多发性硬化症 | 监管合作伙伴关系
> 参加/主持与政策制定者/监管机构的会议 | 10,000 | National | Regularly | 115020534401 |
| Participation in meetings of the AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System] Transparency Council, as well as meetings at the Ministry of Health, including with the Department of Medicines Policy and Pharmacy. | 慢性
> 自助小组 | 监管合作伙伴关系
> 参加/主持与政策制定者/监管机构的会议 | 5,000 | National | Regularly | 115028436607 |
| ... Direct meetings with representatives of the Ministry of Health [in Poland] and NFZ [Narodowy Fundusz Zdrowia – National Health Fund]; participation in conferences and debates involving the MZ [Ministerstwo Zdrowia – Ministry of Health], NFZ, and AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System]. | 总体健康
> 肥胖症 | 监管合作伙伴关系
> 参加/主持与政策制定者/监管机构的会议 | 100,000 | National | Regularly | 115034209832 |
| Participation in meetings of the Transparency Council of AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System]. | 呼吸系统
> 肺纤维化 | 监管合作伙伴关系
> 参加/主持与政策制定者/监管机构的会议 | 100 | National | Rarely | 115044635845 |
| … convening meetings in the Sejm [lower house of the bicameral parliament of Poland] and the Senate. | 稀有
> 罕见病：大多数类型 | 监管合作伙伴关系
> 参加/主持与政策制定者/监管机构的会议 | 100,000 | National | Regularly | 115051819029 |
| Our activities include organising discussion panels with representatives of regulatory authorities. | 稀有
> 罕见病：大多数类型 | 监管合作伙伴关系
> 参加/主持与政策制定者/监管机构的会议 | 100,000 | National | Regularly | 115051819029 |
| The Sejm [lower house of the bicameral parliament of Poland] and the Senate. | 癌症
> 癌症：血液 | 监管合作伙伴关系
> 参加/主持与政策制定者/监管机构的会议 | 100 | National | Rarely | 115055421449 |
| Petitions, meetings, position statements, and ministerial engagements. | 血液
> 血液疾病：大多数类型 | 影响政策和立法
> 影响医疗保健政策和立法 | 100 | Not specified | Regularly | 115004706817 |
| Organising discussion panels with the participation of regulatory authority representatives; holding meetings in the Sejm (lower house of parliament) and the Senate; engaging with parliamentary working groups, committees, and councils operating under the Minister of Health and the Patient Rights Ombudsman. | 稀有
> 罕见病：大多数类型 | 影响政策和立法
> 影响医疗保健政策和立法 | 100,000 | National | Regularly | 115051819029 |
| Petitions, meetings, position statements, and ministerial engagements. | 血液
> 血液疾病：大多数类型 | 影响政策和立法
> 参与公众听证会和咨询 | 100 | Not specified | Regularly | 115004706817 |
| Consultations concerning the Governmental Legislative Process and, for example, draft directives issued by the President of the NFZ [Narodowy Fundusz Zdrowia – National Health Fund] regarding the terms and conditions for entering into and implementing contracts in the area of hospital treatment within the scope of chemotherapy. | 癌症
> 癌症：血液 | 影响政策和立法
> 参与公众听证会和咨询 | 1,000 | National | Sometimes | 115006821188 |
| Petitions, position statements, and public speaking engagements. | 癌症
> 癌症：血液 | 影响政策和立法
> 参与公众听证会和咨询 | We do not communicate with patients directly | National | Regularly | 115008148315 |
| The Sejm [lower house of the bicameral parliament of Poland], parliamentary committees, and the Patient Rights Ombudsman. | 癌症
> 癌症：血液 | 影响政策和立法
> 参与公众听证会和咨询 | 1,000 | National | Sometimes | 115009429955 |
| Parliamentary committee sessions, and presentations delivered within national panel discussions at conferences. | 肾脏
> 肾脏疾病 | 影响政策和立法
> 参与公众听证会和咨询 | 100,000 | National | Regularly | 115055443581 |
| Petitions, meetings, position statements, and ministerial engagements. | 血液
> 血液疾病：大多数类型 | 影响政策和立法
> 动员议员和政治领导人 | 100 | Not specified | Regularly | 115004706817 |
| AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff Setting] consultations concerning an innovative therapy for paediatric patients with NF [Neurofibromatosis]. | 神经系统
> 神经纤维瘤病（NF） | 影响政策和立法
> 解决医疗保健中的障碍/异常问题 | 1,000 | National | Rarely | 115040684008 |
| Consultations concerning the Governmental Legislative Process and, for example, draft directives issued by the President of the NFZ [Narodowy Fundusz Zdrowia – National Health Fund] regarding the terms and conditions for entering into and implementing contracts in the area of hospital treatment within the scope of chemotherapy. | 癌症
> 癌症：血液 | 定价与可负担性倡导
> 参与价格审查委员会谈判 | 1,000 | National | Sometimes | 115006821188 |
| Participation in subcommittees of the Sejm [lower house of the bicameral parliament of Poland] and at AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff Setting]. | 神经肌肉
> 神经肌肉疾病：大多数类型 | 定价与可负担性倡导
> 参与价格审查委员会谈判 | 100 | National | Regularly | 115016498985 |
| Patients have one reimbursed therapy; we therefore participated in AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff Setting] consultations on that single occasion [in Poland]. | 神经系统
> 神经纤维瘤病（NF） | 定价与可负担性倡导
> 倡导将产品纳入报销目录/国家处方集 | 10,000 | National | Rarely | 115001091579 |
| Consultations concerning the Governmental Legislative Process and, for example, draft directives issued by the President of the NFZ [Narodowy Fundusz Zdrowia – National Health Fund] regarding the terms and conditions for entering into and implementing contracts in the area of hospital treatment within the scope of chemotherapy. | 癌症
> 癌症：血液 | 定价与可负担性倡导
> 倡导将产品纳入报销目录/国家处方集 | 1,000 | National | Sometimes | 115006821188 |
| Several years ago, we were consulted on an anti-epileptic medicine with regard to its inclusion on the list of medicines available free of charge. | 神经系统
> 癫痫 | 定价与可负担性倡导
> 倡导将产品纳入报销目录/国家处方集 | 1,000 | National | Rarely | 115060454872 |
| We identify areas in which access to innovative therapies is restricted relative to international guidelines. | 癌症
> 癌症：大多数类型 | 改善访问路径
> 促进公平获取药品/医疗保健 | 100,000 | National | Sometimes | 115016953105 |
| ... Submission of formal written communications addressing patient needs. | 总体健康
> 肥胖症 | 循证患者意见
> 利用患者洞察来指导决策 | 100,000 | National | Regularly | 115034209832 |
| Several years ago, we were consulted on an anti-epileptic medicine with regard to its inclusion on the list of medicines available free of charge. | 神经系统
> 癫痫 | 循证患者意见
> 利用患者洞察来指导决策 | 1,000 | National | Rarely | 115060454872 |
| The Sejm [lower house of the bicameral parliament of Poland], parliamentary committees, and the Patient Rights Ombudsman. | 癌症
> 癌症：血液 | 机构治理
> 确保在政府咨询机构中的代表性 | 1,000 | National | Sometimes | 115009429955 |
| Participation in subcommittees of the Sejm [lower house of the bicameral parliament of Poland] and at AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff Setting]. | 神经肌肉
> 神经肌肉疾病：大多数类型 | 机构治理
> 确保在政府咨询机构中的代表性 | 100 | National | Regularly | 115016498985 |
| Permanent membership of the Expert Team on Obesity Prevention, attached to the Public Health Council [in Poland]. | 总体健康
> 肥胖症 | 机构治理
> 确保在政府咨询机构中的代表性 | 100,000 | National | Regularly | 115034209832 |
| The Sejm [lower house of the bicameral parliament of Poland], the Senate, MZ [Ministerstwo Zdrowia – Ministry of Health], NFZ [Narodowy Fundusz Zdrowia – National Health Fund], RPP [Rada Przejrzystości – Transparency Council]. | 癌症
> 癌症：大多数类型 | 机构治理
> 确保在政府咨询机构中的代表性 | 10,000 | National | Regularly | 115035934051 |
| Organising discussion panels with the participation of regulatory authority representatives; holding meetings in the Sejm (lower house of parliament) and the Senate; engaging with parliamentary working groups, committees, and councils operating under the Minister of Health and the Patient Rights Ombudsman. | 稀有
> 罕见病：大多数类型 | 机构治理
> 确保在政府咨询机构中的代表性 | 100,000 | National | Regularly | 115051819029 |
| The Sejm [lower house of the bicameral parliament of Poland], the Senate, MZ [Ministerstwo Zdrowia – Ministry of Health], NFZ [Narodowy Fundusz Zdrowia – National Health Fund], RPP [Rada Przejrzystości – Transparency Council]. | 癌症
> 癌症：大多数类型 | 机构治理
> 在多利益相关方网络中高效协作 | 10,000 | National | Regularly | 115035934051 |
互动
行动与倡导
20 提及
